Table 2.
Bivariate analysis results between risk factors and prostate volume.
| Risk factor | Prostate volume |
|
|---|---|---|
| r-score | p-Value | |
| Age (year) | 0.098 | 0.377 |
| Body mass index (kg/m2) | 0.007 | 0.953 |
| Fasting plasma glucose (mg/dL) | −0.201 | 0.068 |
| Plasma glucose 2 h post prandial (mg/dL) | −0.147 | 0.186 |
| Total cholesterol (mg/dL) | 0.011 | 0.922 |
| Triglyceride (mg/dL) | 0.002 | 0.986 |
| PSA (ng/mL) | 0.626 | 0.001 |
| Testosterone (ng/mL) | 0.208 | 0.059 |
| TNF-α (pg/mg) | −0.089 | 0.423 |
| TGF-β (pg/mg) | 0.000 | 0.998 |
| Urine culture results | −0.117 | 0.294 |
PSA, prostate-specific antigen; TNF, tumor necrosis factor; TGF, transforming growth factor.
∗Bivariate analysis is performed using the spearman method based on the variables' data scale to evaluate the relationship between each variable and prostate volume.